Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

This study is currently recruiting participants.

Verified January 2013 by H. Lee Moffitt Cancer Center and Research Institute

Sponsor:

Collaborator:

Celgene Corporation

Information provided by (Responsible Party):

H. Lee Moffitt Cancer Center and Research Institute

ClinicalTrials.gov Identifier:

NCT01432600

First received: September 9, 2011

Last updated: January 29, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	October 2013
Estimated Primary Completion Date:	October 2013 (Final data collection date for primary outcome measure)